TELA Bio (TELA) Gross Profit (2018 - 2026)

TELA Bio has reported Gross Profit for 9 years, with the latest figure at $12.5 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit changed 0.06% year-over-year to $12.5 million; the trailing twelve-month figure through Mar 2026 stood at $54.3 million (up 14.03% YoY), and the FY2025 full-year result was $54.3 million, up 16.89% from the prior year.
• Gross Profit for Q1 2026 stood at $12.5 million, down from $13.8 million in the prior quarter.
• The five-year high for Gross Profit was $14.1 million in Q2 2025, with the low at $5.0 million in Q1 2022.
• Average Gross Profit over 5 years is $10.6 million, with a median of $11.2 million recorded in 2024.
• Year-over-year, Gross Profit jumped 59.04% in 2022 and fell 3.47% in 2024.
• Tracing TELA's Gross Profit over 5 years: stood at $8.2 million in 2022, then surged by 42.17% to $11.6 million in 2023, then dropped by 3.47% to $11.2 million in 2024, then rose by 22.58% to $13.8 million in 2025, then fell by 8.98% to $12.5 million in 2026.
• The last three Gross Profit figures came in at $12.5 million (Q1 2026), $13.8 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.

Peer Comparison